本文报道了3所医院中肿瘤病人应用奥丹西隆(ondansetron.又名枢复宁)的评估.制订的应用奥丹西隆的疗效评定标准经各医院药学治疗学委员会或医务人员执行委员会批准.奥丹西隆仅用于成年病人,疗程为4个月,同时进行监护.复习了护理和医疗记录,访问接受治疗的患者.收集有关病人的人口统计学、用药史、奥丹西隆剂量、治疗结果、不良作用及合用药物等资料.按批准的疗效评定标准评估奥丹西隆疗法的可行性、有效性及安全性等. This article reports on the evaluation of ondansetron (ondansetron), a tumor patient in three hospitals. The application of Ondansetron’s efficacy evaluation criteria was approved by the hospital’s pharmacological treatment committee or medical staff executive committee. Ondansetron is for adult patients only, with a 4-month course of care and monitoring at the same time. Review of nursing and medical records, visits to treated patients. Collect patient demographics, medication history, ondansetron doses , Treatment outcomes, adverse effects, and drug combinations. Evaluate the feasibility, effectiveness, and safety of ondansetron therapy according to the approved efficacy assessment criteria.